← Eichor
Condition: Actinic Keratoses Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Actinic Keratoses

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

An Open-Label, Two-Cohort, Pharmacokinetic Study in a Maximal Use Setting for Patients With Actinic Keratosis on the Upp
Phase 1 · 1 location(s) · Sun Pharmaceutical Industries Limited · NCT07729579The Effect of Topical Imipramine on Photodynamic Therapy-Mediated Immunosuppression on Forearms or Face on US Veterans
Phase 2 · 1 location(s) · VA Office of Research and Development · NCT06778434Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp
Phase 3 · 10 location(s) · Sun Pharmaceutical Industries, Inc. · NCT07144345Investigation of the Effect of Lipikar Baume AP+M
NA · 1 location(s) · CentroDerm GmbH · NCT06385340A Pilot Clinical Trial Comparing Topical Fluorouracil to Fluorouracil Plus Calcipotriene Field Treatments in Patients Wi
Phase 3 · 1 location(s) · M.D. Anderson Cancer Center · NCT06851507A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients
EARLY_Phase 1 · 2 location(s) · Marissa Lobl · NCT07286318The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population
NA · 1 location(s) · Wright State University · NCT06428721The Effect of Topical Imipramine on Pain and Effectiveness of Topical Photodynamic Therapy
Phase 1 · 1 location(s) · Wright State University · NCT05688904Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia
NA · 1 location(s) · Wright State University · NCT03906253Phase 3 - Evaluation of Veregen® 10% Ointment as New Herbal Topical Treatment for Actinic Keratosis
Phase 3 · 1 location(s) · Aresus Pharma GmbH · NCT07137819SYsteMatical Trained learnIng aLgorithms for Oral carcInogenesiS Interpretation by Optical Coherence Tomography
Phase N/A · 1 location(s) · University of Palermo · NCT06321003Actinic Keratoses Treated With 5-fluorouracil Plus Aluminum
Phase 1 · 1 location(s) · West Virginia University · NCT07401277A Phase Ib Study of HW211026 Ointment in Patients With Actinic Keratosis.
Phase 1 · 1 location(s) · Hubei Bio-Pharmaceutical Industrial Technological Institute · NCT07318675Combination Therapy of 5-Fluorouracil and CALcipotriol Versus 5-Fluorouracil in the Treatment of Actinic Keratosis
Phase 4 · 4 location(s) · Maastricht University Medical Center · NCT06499415Outcomes Associated With Tirbanibulin for Large Field Application on the Face in the U.S (CLEAR)
Phase N/A · 2 location(s) · Avant Health LLC · NCT07657988Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities
Phase 3 · 20 location(s) · Sun Pharmaceutical Industries, Inc. · NCT07144852Stratification of Cutaneous Squamous Cell Carcinomas According to Its Transcriptomic, Metabolic and Inflammatory Charact
NA · 1 location(s) · University Hospital, Bordeaux · NCT06476964Investigation of the Efficacy and Tolerability of Topical Applied Tirbanibulin on Actinic Keratoses With Downward-direct
Phase N/A · 1 location(s) · Thomas Dirschka · NCT06648447Study of the Photoprotection and Prevention of Actinic Damage With Anthelios Fluide 100 KA+ UVMune 400 in Patients With
NA · 1 location(s) · Cosmetique Active International · NCT07335003Evaluate RLS-1496 Topical Cream for Actinic Keratosis
Phase 1/Phase 2 · 4 location(s) · Rubedo Life Sciences, Inc. · NCT07340697
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.